Mahutte N

No ORCID on file · 6 papers in corpus
2025
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.70131

ProblemA proportion of patients with unexplained recurrent implantation failure (uRIF) may have endometrial immune dysregulation amenable to treatment. Ultimpro (Matrice lab Innove, Paris, France) is an endometrial immunophenotype test whic…

observational 2024
Scientific reports ·doi:10.1038/s41598-024-54423-z

The effectiveness of intravenous immunoglobulin (IVIg) for patients with unexplained recurrent implantation failure (uRIF) remains debated. We retrospectively analysed outcomes of uRIF patients treated with IVIg compared to a separate contr…

other 2019
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-019-01447-4

PURPOSE: Hormonal stimulation prior to IVF influences the ovarian environment and therefore impacts oocytes and subsequent embryo quality. Not every patient has the same response to the same treatment and many fail for unknown reasons. Know…

observational 2008
Surgical oncology ·doi:10.1016/j.suronc.2008.01.002

OBJECTIVE: Few studies examining the association of endometriosis with the risk of breast cancer. Our goal was to investigate the familial risk of breast cancer in women with endometriosis. DESIGN: Retrospective study. SETTING: University…

observational 2007
Fertility and sterility ·doi:10.1016/j.fertnstert.2007.01.037

OBJECTIVE: To investigate the response to controlled ovarian hyperstimulation and ART outcomes in women with advanced-stage endometriosis and previous surgeries at the Yale IVF program between 1996 and 2002. DESIGN: Retrospective case cont…

case-report 2006
Fertility and sterility ·doi:10.1016/j.fertnstert.2005.12.044

OBJECTIVE: To report a case of endometriosis associated with massive ascites, pleural effusion, and extremely elevated Ca-125. DESIGN: Case report. SETTING: University hospital. PATIENT(S): A 46-year-old, white nulligravida with bilatera…